Characterization of the likelihood continual reassessment method

DOI10.1093/BIOMET/ASU012MaRDI QIDQ3191468zbMATH OpenOpenAlexFDO

Authors Xiao-Yu Jia, Shing M. Lee, Ying Kuen Cheung

Publication date 2 October 2014

Published in Biometrika (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1093/biomet/asu012

zbMATH Keywords

adaptive designclinical trialcoherencedose findingindifference interval

Mathematics Subject Classification ID

Sequential statistical design (62L05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Continual reassessment and related dose-finding designs
• A note on continual reassessment method
• Consistency of continual reassessment method under model misspecification
• A new design of the continual reassessment method
• On the consistency of the continual reassessment method with multiple toxicity constraints

Cited in

(8)

• Curve-free and model-based continual reassessment method designs
• TWO-SAMPLE CONTINUAL REASSESSMENT METHOD
• A new design of the continual reassessment method
• Impact of different model structure and prior distribution in continual reassessment method
• Toxicity-dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
• Performance of toxicity probability interval based designs in contrast to the continual reassessment method
• A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials
• Identifying a maximum tolerated contour in two-dimensional dose finding

This page was built for publication: Characterization of the likelihood continual reassessment method

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3191468)